Pharmacokinetic

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Research and Markets: The Biochemistry of Drug Metabolism: Two Volume Set

Published February 9, 2010, 6:11 am, Business Wire via Yahoo! Finance

DUBLIN----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "The Biochemistry of Drug Metabolism: Two Volume Set" to their offering.

Discover News | Full Story


Ardea Biosciences Announces Appointment of Felix J. Baker, Ph.D. to Board of Directors

Published February 9, 2010, 5:30 am, PR Newswire via Yahoo! Finance

Ardea Biosciences, Inc. today announced that Felix J. Baker, Ph.D., has been appointed to the Company's Board of Directors. Â Dr. Baker is a managing partner of Baker Bros. Advisors, LLC, the manager and advisor to the funds of Baker Brothers Investments, Ardea's largest shareholder.

Discover News | Full Story


Genta commences treatment in tesetaxel Phase 2 trial for advanced melanoma

Published February 8, 2010, 9:17 pm, News-Medical-Net

Genta Incorporated announced that the Company has initiated treatment of the first subject in a new Phase 2 trial of tesetaxel in advanced melanoma. Tesetaxel is the Company’s newest clinical-stage small molecule. As a late Phase 2 oncology product, tesetaxel is the leading oral taxane currently in clinical development. The new trial builds on more than ten years of Genta’s experience in ...

Discover News | Full Story


Addex: ADX71943 Demonstrates Analgesic Effects In Pain Models

Published February 8, 2010, 6:35 am, Medical News Today

Addex Pharmaceuticals / Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Addex Pharmaceuticals (SWISS: ADXN), the allosteric modulation company, announced today that ADX71943 has demonstrated statistically significant analgesic-like effects in three preclinical models of ...

Discover News | Full Story


Press Release

Published February 8, 2010, 5:10 am, PharmiWeb

Paloma Pharmaceuticals Inc. Posted on:05 Feb 10 JAMAICA PLAIN, Massachusetts, February 4 /PRNewswire/ -- Paloma Pharmaceuticals, Inc. announced today that it has received acceptance of its IND to enter Phase I studies with Palomid 529 (P529) in patients with age-related macular degeneration (AMD). The Phase I study, "A Phase I Open-Label Study to Investigate the Safety, Tolerability and ...

Discover News | Full Story


Press Release

Published February 8, 2010, 5:10 am, PharmiWeb

Biotrial, a key CRO player for early drug development in healthy volunteers and patients, to exhibit at two major life science conferences in February 2010.

Discover News | Full Story


Genta Initiates Phase 2 Study of Tesetaxel, the Leading Clinical-Stage Oral Taxane, in Patients with Advanced Melanoma

Published February 8, 2010, 5:05 am, Business Wire via Yahoo! Finance

BERKELEY HEIGHTS, N.J.----Genta Incorporated announced that the Company has initiated treatment of the first subject in a new Phase 2 trial of tesetaxel in advanced melanoma. Tesetaxel is the Company’s newest clinical-stage small molecule.

Discover News | Full Story


Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models

Published February 7, 2010, 10:13 pm, Marketwire

GENEVA, SWITZERLAND--(Marketwire - February 8, 2010) -

Discover News | Full Story


Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models

Published February 7, 2010, 10:08 pm, Marketwire via Yahoo! Finance

GENEVA, SWITZERLAND--(Marketwire - 02/08/10) - Addex Pharmaceuticals / Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models processed and transmitted by Hugin AS. The issuer is solely responsible for the content of this announcement. Addex Pharmaceuticals (Swiss: ADXN - News ), the allosteric modulation company, announced today that ADX71943 has demonstrated statistically significant ...

Discover News | Full Story


Health Information Technologies for Practicing Psychiatrists

Published February 7, 2010, 8:02 pm, Psychiatric Times

Dr Luo is associate clinical professor in the department of psychiatry of the UCLA Semel Institute for Neuroscience and Human Behavior in Los Angeles. He reports no conflicts of interest concerning the subject matter of this article.

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a